Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank57
Studio
Year-over-Year Change

Return on equity

Latest
-45.18%
↓ 228% vs avg
Percentile
P57
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
35.39%
Historical baseline
PeriodValueYoY Change
2025-45.18%-110.0%
2024452.87%+575.6%
2023-95.22%-3.0%
2022-92.44%-33.1%
2021-69.47%-40.8%
2020-49.33%-161.2%
201980.54%-20.5%
2018101.35%-